TABLE 2

Prevalence of WHO- and NCEP-defined MetS and syndrome components among nondiabetic IRAS participants, by ethnicity and glucose tolerance status

VariableAll subjects
Non-Hispanic whites
Blacks
Hispanics
NFG/NGTIFG/IGTNFG/NGTIFG/IGTNFG/NGTIFG/IGTNFG/NGTIFG/IGT
WHO Mets17.160.611.757.213.056.526.5§67.7
 Central/total obesity45.672.543.471.738.567.653.5*77.2
 Raised arterial pressure26.642.223.836.536.055.622.838.2
 High Tg and/or low HDL36.650.537.551.621.129.647.0§65.9§
 Microalbuminuria6.25.58.64.44.410.24.72.9
NCEP MetS15.245.214.142.86.842.622.8§50.0
 Abdominal obesity22.244.718.842.823.648.225.144.1
 Elevated triglycerides25.338.327.736.313.719.431.255.6§
 Reduced HDL46.256.144.955.729.840.760.0§68.9§
 Elevated BP39.657.337.550.949.770.434.454.4
 Fasting hyperglycemia0.039.50.036.50.052.80.032.4
  • Data are %.

  • *

    * P < 0.05;

  • P < 0.01;

  • P < 0.001;

  • §

    § P < 0.0001; P values reflect overall differences across ethnic groups, by glucose tolerance status. NFG, normal fasting glucose; Tg, triglyceride.